Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 11, 2023 09:51 ET | Source: BTG Specialty Pharmaceuticals

Largest study to date of high-dose methotrexate associated acute kidney injury supports the use of Voraxaze® (glucarpidase)

West Conshohocken, PA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- BTG Pharmaceuticals, a SERB company, announces the presentation of the largest study to date of patients with high-dose methotrexate (HDMTX)...
October 20, 2004 08:58 ET | Source: Vitrolife

Vitrolife Signs Research Agreement With Dr. Peter Svalander

STOCKHOLM, Sweden, Oct. 20, 2004 (PRIMEZONE) -- Vitrolife has signed a research agreement with Dr. Peter Svalander, the founder and former CEO of the company, regarding product development within the...
September 10, 2003 09:43 ET | Source: Pharmexa A/S

Pharmexa Reports Progress in U.S. Breast Cancer Trial

HORSHOLM, Denmark, Sept. 10, 2003 (PRIMEZONE) -- Summary: Recruitment of patients to the US phase I breast cancer trial with Pharmexa's (Other OTC:PMXAY) HER-2 AutoVac(TM) Protein vaccine has now...
March 27, 2003 03:06 ET | Source: Karo Bio

Abbott Laboratories and Karo Bio Identify Novel new Compound for Diabetes

HUDDINGE, Sweden, March 27, 2003 (PRIMEZONE) -- Abbott Laboratories and Karo Bio AB (Other OTC:KARBF) today announced that they have identified a novel, first-in-class compound, A-348441, for the...
March 18, 2003 11:18 ET | Source: Index Ventures

Cellzome Hits Target on Series C Financing

Heidelberg, Germany, March 18, 2003 - Cellzome today announced the completion of its Series C funding at a total of approximately 30 Million Pounds. Lead investor, INVESCO Private Capital, was...
September 13, 2002 09:25 ET | Source: CeNeS Pharmaceuticals Plc

CeNeS Pharmaceuticals plc: Interim Results Notification

CAMBRIDGE, United Kingdom, Sept. 13, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) will be announcing its interim results for the six months ended 30 June 2002 on Monday 30th September...
August 29, 2002 07:07 ET | Source: Carlsberg A/S

Carlsberg A/S: Combio Negotiating with Potential Customers

VALBY, Denmark, Aug. 29, 2002 (PRIMEZONE) -- In less than two years, the biotech company Combio A/S has managed to build up the company to start research and development of new, potential drug...